An interventional study of Robotic Hand Therapy and Conventional physical Therapy in Cerebral Palsy, Hemiplegic, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 7 Years to 15 Years. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Riphah International University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 135 studies in Cerebral Palsy by Riphah International University — 37 open to participants now, 37 under way, none of them phase 3. Cerebral Palsy · Riphah International University.
Among the 135 studies in Cerebral Palsy by Riphah International University, this one is the 6th largest by planned enrollment of the 125 interventional ones that give a count, is one of 18 that started in 2026, is one of 125 with no phase, reaches primary completion later than 34 of the 36 other live ones, and was the 120th registered.
1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.
Browse Cerebral Palsy studies →37 of the 135 studies in Cerebral Palsy by Riphah International University are open now, in 1 country. Recruiting first, the newest first:
Riphah International University · Sites in Pakistan
Ages 4–10
Riphah International University · Sites in Pakistan
Ages 4–12
Riphah International University · Sites in Pakistan
Ages 4–18
Riphah International University · Sites in Pakistan
Ages 8–16
Riphah International University · Sites in Pakistan
Ages 8–16
By country, each count listing its studies:
Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.
This study: 7 Years to 15 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
135 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 18 started in 2026.
This study's planned enrollment of 70 is above the median of 34 across 1,434 interventional studies indexed under Cerebral Palsy.
Median enrollment 30 across the 125 interventional studies, 108 across the 10 observational. Of the 89 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Riphah International University is the lead sponsor of 2,201 studies on the registry; 647 are open to participants now.
8 of the studies in Cerebral Palsy by Riphah International University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07921186Riphah International UniversityComparison of Vestibular Stimulation and Core Stability Training on Sitting Balance in Hypotonic CP | 2027-03 |
| NCT07733570Riphah International UniversityEffects of Sensory Integration Therapy in Children With Spastic Hemiplegic Cerebral Palsy | 2027-03-22 |
| NCT07629024Riphah International UniversityRehabilitation Assessment of Motor Function In Cerebral Palsy Using Explainable AI | 2027-03-30 |
| NCT07921069Riphah International UniversitySensory Integration Therapy vs Conventional Physical Therapy in Children With Mixed Cerebral Palsy | 2027-04 |
| NCT07921147Riphah International UniversityTelerehabilitation Compared With Clinic-Based Physiotherapy in Children With Spastic Cerebral Palsy | 2027-04-05 |
Add all 8 to your calendar (.ics) → With an account.
Among the 135 studies in Cerebral Palsy by Riphah International University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial aims to evaluate the effects of robotic hand therapy using the Syrebo E12 soft-robotic glove compared with conventional physiotherapy on hand function and manual dexterity in children with hemiplegic cerebral palsy. Children aged 7-15 years, classified as GMFCS I-III and MACS I-III, will be recruited from multiple rehabilitation centers in Pakistan. Participants will be randomly allocated (1:1) to either robotic therapy or standard physiotherapy, receiving 45-minute sessions, three times per week for 8 weeks.
The primary outcome is functional hand performance measured by the Jebsen-Taylor Hand Function Test (JTHFT). Secondary outcomes include ABILHAND-Kids, Box and Block Test, Nine-Hole Peg Test, grip strength, and qualitative feedback. Assessments will occur at baseline, week 4, week 8, and at a 6-month follow-up. A mixed-effects repeated-measures ANCOVA will be used for analysis following the intention-to-treat principle.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: Robotic Hand Therapy
Other: Conventional physical Therapy
Participants in this group will receive robotic hand therapy using a glove-based robotic rehabilitation device that provides passive, active-assisted, and resistive training to facilitate repetitive, task-specific hand movements. Each 45-minute session will be delivered three times per week for six weeks under therapist supervision, focusing on improving grasp-release patterns, finger mobility, and functional hand use. Therapy intensity will be progressively adjusted based on performance and tolerance, and all sessions will be monitored for safety and adverse events.
Participants in this group will receive conventional physical therapy based on neurodevelopmental and task-oriented principles, including stretching, strengthening, sensory re-education, and functional hand-use training. Sessions will last 45 minutes, three times per week for six weeks, delivered by a licensed physical therapist following a standardized treatment checklist. The program targets improvements in hand strength, dexterity, range of motion, and fine motor skills, with safety and treatment fidelity monitored throughout.
Jebsen-Taylor Hand Function Test
Jebsen-Taylor Hand Function Test (JTHFT) will objectively quantify functional capacity of hand.
Time frame: 8 Weeks
ABILHAND-Kids
ABILHAND-Kids for perceived manual ability in daily activities (Subjective assessment).
Time frame: 8 Weeks
Box and Block Test
Box and Block Test \[BBT\] for unilateral gross manual dexterity
Time frame: 8 Weeks
Nine-Hole Peg Test (NHPT)
Nine-Hole Peg Test (NHPT) fine finger dexterity (time to place and remove pegs)
Time frame: 8 weeks
o'connor test
The O'Connor Finger Dexterity Test is a, standardized, timed, aptitude assessment designed to measure fine motor skills and rapid, precise manipulation of small objects. It is widely used in vocational testing, industrial hiring (assembly line work), and clinical rehab to evaluate finger dexterity by placing three pins into 100 holes.
Time frame: 8 Weeks
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2026 (actual). Primary completion is estimated for Jun 2027, 7 months after the start.
Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 7 months is below that.
Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.
Start moved once since we started tracking on Sep 25, 2026: May 2026 → Nov 2026, on Nov 18, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Riphah International University →